NEW YORK, May 11, 2017 /PRNewswire/ — Rosen Law Firm, a global investor rights law firm, announces it is continuing to investigate potential securities claims on behalf of shareholders of Intra-Cellular Therapies, Inc. (NASDAQ: ITCI) resulting from allegations that Intra-Cellular…
May 12, 2017 at 02:00AM
from
No comments:
Post a Comment